Less than 1 min.Read

Cecelia Health: Closes $13M Series B Financing

August 17, 2020

Cecelia Health, a NYC-based technology-enabled diabetes and other chronic disease management company, closed a $13m Series B funding round
The round co-led by Rittenhouse Ventures and Endo Investors, with participation from Boston Millennia Partners, SustainVC, G100 Capital, and others
The company intends to use the funds to accelerate and further scale the adoption of its technology enabled coaching
Cecelia Health will leverage the new funding to deliver a commercial Virtual Clinic that will offer CGM training
Cecelia Health has emerged as a leader in using expert clinicians that leverage a technology-enabled digital health platform
Later this month, Cecelia Health will serve as a contractor to The Jaeb Center for Health Research to conduct a study of a virtual diabetes